1-naphthyl isothiocyanate decreases expression EXP 6480464 1-Naphthylisothiocyanate results in decreased expression of KCNK2 mRNA CTD PMID:30723492 14-Deoxy-11,12-didehydroandrographolide decreases expression ISO RGD:1354126 6480464 14-deoxy-11, 12-didehydroandrographolide results in decreased expression of KCNK2 mRNA CTD PMID:22101062 17alpha-ethynylestradiol affects expression EXP 6480464 Ethinyl Estradiol affects the expression of KCNK2 mRNA CTD PMID:26865667 17beta-estradiol 3-benzoate increases methylation EXP 6480464 estradiol 3-benzoate results in increased methylation of KCNK2 promoter CTD PMID:27415467 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:732064 6480464 Tetrachlorodibenzodioxin results in increased expression of KCNK2 mRNA CTD PMID:19933214 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of KCNK2 mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:732064 6480464 Tetrachlorodibenzodioxin affects the expression of KCNK2 mRNA CTD PMID:21570461 2,4-diaminotoluene increases expression ISO RGD:732064 6480464 2, 4-diaminotoluene results in increased expression of KCNK2 mRNA CTD PMID:20713471 3,4-methylenedioxymethamphetamine decreases expression EXP 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in decreased expression of KCNK2 mRNA CTD PMID:30071829 3-methylcholanthrene increases expression ISO RGD:732064 6480464 Methylcholanthrene results in increased expression of KCNK2 mRNA CTD PMID:20713471 4-hydroxyphenyl retinamide decreases expression ISO RGD:732064 6480464 Fenretinide results in decreased expression of KCNK2 mRNA CTD PMID:28973697 6-propyl-2-thiouracil affects expression EXP 6480464 Propylthiouracil affects the expression of KCNK2 mRNA CTD PMID:24780913 acetamide decreases expression EXP 6480464 acetamide results in decreased expression of KCNK2 mRNA CTD PMID:31881176 acrylamide decreases expression EXP 6480464 Acrylamide results in decreased expression of KCNK2 mRNA CTD PMID:28959563 aflatoxin B1 increases methylation ISO RGD:1354126 6480464 Aflatoxin B1 results in increased methylation of KCNK2 intron CTD PMID:30157460 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of KCNK2 mRNA CTD PMID:16483693 arachidonic acid multiple interactions ISO RGD:1354126 6480464 Arachidonic Acid promotes the reaction [KCNK2 protein results in increased transport of Potassium] CTD PMID:16075240 aristolochic acid A decreases expression ISO RGD:1354126 6480464 aristolochic acid I results in decreased expression of KCNK2 mRNA CTD PMID:33212167 arsenite(3-) increases methylation ISO RGD:1354126 6480464 arsenite results in increased methylation of KCNK2 promoter CTD PMID:23974009 arsenous acid decreases expression ISO RGD:1354126 6480464 Arsenic Trioxide results in decreased expression of KCNK2 mRNA CTD PMID:26705709 benzo[a]pyrene decreases expression EXP 6480464 Benzo(a)pyrene results in decreased expression of KCNK2 mRNA CTD PMID:21839799 benzo[a]pyrene affects methylation ISO RGD:1354126 6480464 Benzo(a)pyrene affects the methylation of KCNK2 exon, Benzo(a)pyrene affects the methylation of KCNK2 intron CTD PMID:27901495 , PMID:30157460 benzo[a]pyrene increases methylation ISO RGD:732064 6480464 Benzo(a)pyrene results in increased methylation of KCNK2 intron CTD PMID:27901495 benzo[a]pyrene increases expression ISO RGD:732064 6480464 Benzo(a)pyrene results in increased expression of KCNK2 mRNA CTD PMID:15034205 , PMID:20713471 benzo[e]pyrene affects methylation ISO RGD:1354126 6480464 benzo(e)pyrene affects the methylation of KCNK2 intron CTD PMID:30157460 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of KCNK2 mRNA CTD PMID:25181051 bisphenol A decreases methylation ISO RGD:1354126 6480464 bisphenol A results in decreased methylation of KCNK2 gene CTD PMID:31601247 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of KCNK2 mRNA CTD PMID:34947998 bisphenol A decreases methylation ISO RGD:732064 6480464 bisphenol A results in decreased methylation of KCNK2 promoter CTD PMID:27312807 bromobenzene increases expression EXP 6480464 bromobenzene results in increased expression of KCNK2 mRNA CTD PMID:32479839 cadmium atom decreases expression ISO RGD:1354126 6480464 Cadmium results in decreased expression of KCNK2 mRNA CTD PMID:24376830 camptothecin decreases response to substance ISO RGD:1354126 6480464 KCNK2 mRNA results in decreased susceptibility to Camptothecin CTD PMID:25269479 CGP 52608 multiple interactions ISO RGD:1354126 6480464 CGP 52608 promotes the reaction [RORA protein binds to KCNK2 gene] CTD PMID:28238834 chlorohydrocarbon multiple interactions EXP 6480464 [Hydrocarbons, Chlorinated co-treated with Polychlorinated Biphenyls co-treated with methylmercuric chloride] results in increased expression of KCNK2 mRNA CTD PMID:30744511 clozapine decreases expression ISO RGD:732064 6480464 Clozapine results in decreased expression of KCNK2 mRNA CTD PMID:15542763 copper atom multiple interactions EXP 6480464 [Copper co-treated with Dietary Sucrose] results in increased expression of KCNK2 mRNA CTD PMID:26033743 copper atom multiple interactions ISO RGD:1354126 6480464 [NSC 689534 binds to Copper] which results in decreased expression of KCNK2 mRNA CTD PMID:20971185 copper(0) multiple interactions EXP 6480464 [Copper co-treated with Dietary Sucrose] results in increased expression of KCNK2 mRNA CTD PMID:26033743 copper(0) multiple interactions ISO RGD:1354126 6480464 [NSC 689534 binds to Copper] which results in decreased expression of KCNK2 mRNA CTD PMID:20971185 coumarin increases expression EXP 6480464 coumarin results in increased expression of KCNK2 mRNA CTD PMID:18480146 dexamethasone increases expression EXP 6480464 Dexamethasone results in increased expression of KCNK2 mRNA, Dexamethasone results in increased expression of KCNK2 protein CTD PMID:21069514 dexamethasone multiple interactions EXP 6480464 Fluoxetine inhibits the reaction [Dexamethasone results in increased expression of KCNK2 mRNA], Fluoxetine inhibits the reaction [Dexamethasone results in increased expression of KCNK2 protein] CTD PMID:21069514 diarsenic trioxide decreases expression ISO RGD:1354126 6480464 Arsenic Trioxide results in decreased expression of KCNK2 mRNA CTD PMID:26705709 dibutyl phthalate increases expression ISO RGD:732064 6480464 Dibutyl Phthalate results in increased expression of KCNK2 mRNA CTD PMID:21266533 dibutyl phthalate increases expression EXP 6480464 Dibutyl Phthalate results in increased expression of KCNK2 mRNA CTD PMID:21266533 diethylstilbestrol decreases expression EXP 6480464 Diethylstilbestrol results in decreased expression of KCNK2 mRNA CTD PMID:17005392 diltiazem multiple interactions ISO RGD:1354126 6480464 Diltiazem inhibits the reaction [KCNK2 protein results in increased transport of Potassium] CTD PMID:16075240 dioxygen multiple interactions ISO RGD:732064 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of KCNK2 mRNA CTD PMID:30529165 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of KCNK2 mRNA CTD PMID:29391264 ethanol affects splicing ISO RGD:732064 6480464 Ethanol affects the splicing of KCNK2 mRNA CTD PMID:30319688 fipronil decreases expression EXP 6480464 fipronil results in decreased expression of KCNK2 mRNA CTD PMID:23962444 flufenamic acid multiple interactions ISO RGD:1354126 6480464 Flufenamic Acid promotes the reaction [KCNK2 protein results in increased transport of Potassium] CTD PMID:16075240 fluoxetine multiple interactions EXP 6480464 Fluoxetine inhibits the reaction [Dexamethasone results in increased expression of KCNK2 mRNA], Fluoxetine inhibits the reaction [Dexamethasone results in increased expression of KCNK2 protein] CTD PMID:21069514 fluoxetine multiple interactions ISO RGD:732064 6480464 [KCNK2 mRNA co-treated with KCNK10 mRNA] affects the susceptibility to Fluoxetine CTD PMID:23022515 fluoxetine decreases activity ISO RGD:732064 6480464 Fluoxetine results in decreased activity of KCNK2 protein CTD PMID:23022515 fluoxetine affects response to substance ISO RGD:732064 6480464 KCNK2 mRNA affects the susceptibility to Fluoxetine CTD PMID:23022515 fluoxetine decreases expression ISO RGD:732064 6480464 Fluoxetine results in decreased expression of KCNK2 mRNA CTD PMID:23022515 fluoxetine decreases response to substance EXP 6480464 Fluoxetine results in decreased susceptibility to KCNK2 protein CTD PMID:21069514 fluoxetine decreases expression EXP 6480464 Fluoxetine results in decreased expression of KCNK2 mRNA, Fluoxetine results in decreased expression of KCNK2 protein CTD PMID:21069514 furan increases methylation EXP 6480464 furan results in increased methylation of KCNK2 gene CTD PMID:22079235 genistein decreases expression ISO RGD:1354126 6480464 Genistein results in decreased expression of KCNK2 mRNA CTD PMID:26865667 genistein increases expression ISO RGD:732064 6480464 Genistein results in increased expression of KCNK2 mRNA CTD PMID:32186404 gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of KCNK2 mRNA CTD PMID:22061828 halothane multiple interactions ISO RGD:1354126 6480464 Halothane promotes the reaction [KCNK2 protein results in increased transport of Potassium] CTD PMID:16075240 lipopolysaccharide decreases expression ISO RGD:732064 6480464 Lipopolysaccharides results in decreased expression of KCNK2 mRNA CTD PMID:12057914 lipopolysaccharide multiple interactions ISO RGD:1354126 6480464 [S-(1 more ... CTD PMID:35811015 mefenamic acid multiple interactions ISO RGD:1354126 6480464 Mefenamic Acid promotes the reaction [KCNK2 protein results in increased transport of Potassium] CTD PMID:16075240 methapyrilene affects methylation ISO RGD:1354126 6480464 Methapyrilene affects the methylation of KCNK2 intron CTD PMID:30157460 methylmercury chloride multiple interactions EXP 6480464 [Hydrocarbons, Chlorinated co-treated with Polychlorinated Biphenyls co-treated with methylmercuric chloride] results in increased expression of KCNK2 mRNA CTD PMID:30744511 Muraglitazar increases expression EXP 6480464 muraglitazar results in increased expression of KCNK2 mRNA CTD PMID:21515302 N,N-diethyl-m-toluamide multiple interactions EXP 6480464 [Permethrin co-treated with DEET] results in decreased methylation of KCNK2 gene CTD PMID:33148267 Niflumic acid multiple interactions ISO RGD:1354126 6480464 Niflumic Acid promotes the reaction [KCNK2 protein results in increased transport of Potassium] CTD PMID:16075240 permethrin multiple interactions EXP 6480464 [Permethrin co-treated with DEET] results in decreased methylation of KCNK2 gene CTD PMID:33148267 potassium atom multiple interactions ISO RGD:1354126 6480464 Arachidonic Acid promotes the reaction [KCNK2 protein results in increased transport of Potassium] more ... CTD PMID:16075240 potassium chromate increases expression ISO RGD:1354126 6480464 potassium chromate(VI) results in increased expression of KCNK2 mRNA CTD PMID:22714537 resveratrol multiple interactions ISO RGD:1354126 6480464 [Plant Extracts co-treated with Resveratrol] results in decreased expression of KCNK2 mRNA CTD PMID:23557933 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO RGD:1354126 6480464 [S-(1 more ... CTD PMID:35811015 S-(1,2-dichlorovinyl)-L-cysteine increases expression ISO RGD:1354126 6480464 S-(1, 2-dichlorovinyl)cysteine results in increased expression of KCNK2 mRNA CTD PMID:35811015 serpentine asbestos decreases methylation ISO RGD:1354126 6480464 Asbestos, Serpentine results in decreased methylation of KCNK2 gene CTD PMID:29523930 silicon dioxide decreases expression EXP 6480464 Silicon Dioxide results in decreased expression of KCNK2 mRNA CTD PMID:32721576 sodium arsenite increases expression ISO RGD:1354126 6480464 sodium arsenite results in increased expression of KCNK2 mRNA CTD PMID:22714537 , PMID:34032870 Soman decreases expression EXP 6480464 Soman results in decreased expression of KCNK2 mRNA CTD PMID:19281266 Tesaglitazar increases expression EXP 6480464 tesaglitazar results in increased expression of KCNK2 mRNA CTD PMID:21515302 trichloroethene increases methylation EXP 6480464 Trichloroethylene results in increased methylation of KCNK2 gene CTD PMID:27618143 triptonide increases expression ISO RGD:732064 6480464 triptonide results in increased expression of KCNK2 mRNA CTD PMID:33045310 valproic acid affects expression ISO RGD:732064 6480464 Valproic Acid affects the expression of KCNK2 mRNA CTD PMID:17292431 vinclozolin increases methylation EXP 6480464 vinclozolin results in increased methylation of KCNK2 gene CTD PMID:31079544
